Parabilis Medicines, Inc.
- PBLS
- NASDAQ
- Biotechnology
- Cancer Therapeutics
- Cell-Penetrating Miniproteins
$22.75
Today −9.65%Quote Oct 16, 2026, 08:00 PM UTC
−44.35%over the last month
Max drawdown −45.5%From 1-month high −45.5%3 months −16.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$657.7M
Approximate share count
Next earnings
Nov 12
Expected, not confirmed
Analyst target
$40.00
+75.8% from here
Floor
$20.79
8.6% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about PBLSPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
145